ABBV Rating

ABBV Intrinsic Value

Key Highlights:
As of Mar 11, 2025 ABBV Relative Value is $149.4, which is overvalued by 30.0%, compared to current share price of $213.6.
As of Mar 11, 2025 ABBV DCF Value is $454.2, which is undervalued by 112.6%, compared to current share price of $213.6.
Methodology
Price per share, $
Current share price
213.6

ABBV Share Price History

1W 2.8%
1M 11.3%
6M 11.7%
YTD 39.8%
1Y 23.2%
3Y 60.4%
5Y 210.7%
10Y 471.7%
Share Price
Intrinsic Value
Drawdown
Total Return
vs SP500
vs NASDAQ
Crunching data... Almost there!

ABBV Stock Metrics

Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
Base
$375.8B
Shares Outstanding
1,759M
Employees
55K
Valuation (LTM)
Return on Capital
90.3%
3.1%
8.3%
9.9%
Earnings
Jul 23, 2025
MISS by (38.0%)
9 Beat & 1 Miss

ABBV Stock Financials

ABBV Income Statement Metrics

Annual
Quarterly
LTM

Revenue

$56.3B +3.7% YoY

Operating Income

$9.1B -28.4% YoY

Net Income

$4.3B -12.0% YoY

ABBV Cash Flow Statement Metrics

Annual
Quarterly
LTM

Operating Cash Flow (OCF)

$18.8B -17.7% YoY

Free Cash Flow (FCF)

$18.8B -19.2% YoY

ABBV Income Statement Overview

Annual
Quarterly
LTM
Dec'15
Dec'16
Dec'17
Dec'18
Dec'19
Dec'20
Dec'21
Dec'22
Dec'23
Dec'24
$56.3B 3.7% YoY
$39.4B 16.3% YoY
70.0% margin
Cost of revenue
$16.9B (17.2%) YoY
Operating income
$9,137.0M (28.4%) YoY
16.2% margin
Other: $3,261.0M
Net interest: $2,160.0M
Operating expenses
$30.3B 43.3% YoY
Pre-tax income
$3,716.0M (40.5%) YoY
6.6% margin
Net income
$4,278.0M (12.0%) YoY
7.6% margin
R&D
$12.8B 51.3% YoY
22.7% of revenue
SG&A
$14.8B 14.6% YoY
26.2% of revenue

ABBV Balance Sheet Overview

Annual
Quarterly
LTM
Dec'15
Dec'16
Dec'17
Dec'18
Dec'19
Dec'20
Dec'21
Dec'22
Dec'23
Dec'24
Assets
Liabilities
Total assets
$135.2B
Current assets ($25.6B, 18.9% of total)
$5,555.0M (4.1%)
Other current assets
$9,108.0M (6.7%)
Non-current assets ($109.6B, 81.1% of total)
$279.0M (0.2%)
$60.1B (44.4%)
Other non-current assets
$44.1B (32.6%)
Financial position
$61.6B
$5,555.0M$67.1B
Cash & Short-term Investments
Total Debt

ABBV Stock Ratios

ABBV Earnings Surprises

Crunching data... Almost there!

ABBV Dividends

ABBV Dividend Yield

Crunching data... Almost there!

ABBV Dividend Per Share

Competing with ABBV

Overview
Ratings
Intrinsic Value
Valuation
Growth
Profitability
Health
Capital allocation
Momentum
Earnings
Dividends
Company name
Market Cap
Quality rating
Intrinsic value
1Y Return
Revenue
Free Cash Flow
Revenue growth
FCF margin
Gross margin
ROIC
Total Debt to Equity
$375.8B
6.0
$302.4
41.6% undervalued
23.2%
$56.3B
$17.8B
3.7%
31.7%
73.6%
8.3%
1,996.0%
$743.9B
7.0
$225.3
72.7% overvalued
12.9%
$45.0B
$510.8M
32.0%
1.1%
81.6%
40.7%
235.7%
$398.7B
5.9
$197.1
18.9% undervalued
6.2%
$88.8B
$18.1B
4.3%
20.3%
69.1%
15.7%
51.2%
$346.3B
7.1
$72.1
7.7% overvalued
(40.0%)
DKK 290.4B
DKK 70.0B
25.0%
24.1%
84.7%
35.5%
71.6%
$240.8B
7.5
$112.5
18.8% undervalued
(20.7%)
$64.2B
$18.1B
6.7%
28.2%
80.8%
26.5%
80.0%
$232.5B
6.7
$69.5
6.3% overvalued
11.9%
$54.1B
$7,275.0M
18.0%
13.5%
81.1%
15.4%
73.7%
$223.3B
6.6
$149.6
34.3% undervalued
9.8%
$51.1B
$13.8B
0.1%
27.0%
74.7%
17.7%
70.8%
$173.1B
5.9
$447.8
40.4% undervalued
19.3%
$33.4B
$10.4B
18.6%
31.1%
61.5%
11.9%
1,022.6%
$148.1B
6.0
$25.3
2.7% overvalued
(2.7%)
$63.6B
$9,835.0M
8.8%
15.5%
65.6%
9.0%
71.9%
$146.8B
4.7
$91.4
55.6% undervalued
25.2%
€44.3B
(€504.0M)
(22.5%)
(1.1%)
70.2%
7.4%
23.0%
$143.2B
6.1
$91.1
20.4% overvalued
58.1%
$28.7B
$10.5B
6.0%
36.4%
78.3%
20.1%
138.8%

FAQ

What is AbbVie Inc. (ABBV) stock rating?

As of today, AbbVie Inc. has a stock rating of 6 (out of 10), which is considered Good.

is AbbVie Inc. (ABBV) a good stock to buy?

As of today, AbbVie Inc. has a Good stock rating, which is 41.6% undervalued. According to Value Sense backtesting, stocks with similar profile tend to outperform the market by 3.2%.